Biograil Raises €20 Million To Advance Oral Drug Delivery Technology Toward Clinical Trials
· pulse2.com · popularity 20/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at pulse2.com →
Summary
Biograil, a Copenhagen-based biotechnology company developing oral delivery technology for medicines that traditionally require injections, has raised €20 million in financing to advance its BIONDD platform toward clinical development. The post Biograil Raises €20 Million To Advance Oral Drug Delivery Technology Toward Clinical Trials appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.